11,526 Shares in Centene Corporation $CNC Acquired by Three Seasons Wealth LLC

Three Seasons Wealth LLC bought a new stake in Centene Corporation (NYSE:CNCFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 11,526 shares of the company’s stock, valued at approximately $740,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. 180 Wealth Advisors LLC raised its holdings in shares of Centene by 3.1% in the 1st quarter. 180 Wealth Advisors LLC now owns 6,683 shares of the company’s stock valued at $219,000 after buying an additional 199 shares during the period. Summitry LLC boosted its holdings in Centene by 1.1% during the 1st quarter. Summitry LLC now owns 23,925 shares of the company’s stock valued at $783,000 after acquiring an additional 253 shares during the period. GAMMA Investing LLC increased its stake in Centene by 2.4% during the second quarter. GAMMA Investing LLC now owns 10,674 shares of the company’s stock worth $685,000 after purchasing an additional 253 shares during the period. Kestra Advisory Services LLC lifted its position in shares of Centene by 0.5% during the fourth quarter. Kestra Advisory Services LLC now owns 52,602 shares of the company’s stock worth $2,165,000 after purchasing an additional 264 shares in the last quarter. Finally, CX Institutional grew its holdings in shares of Centene by 3.1% in the second quarter. CX Institutional now owns 8,999 shares of the company’s stock valued at $578,000 after purchasing an additional 269 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the sale, the general counsel owned 248,854 shares of the company’s stock, valued at approximately $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CNC has been the subject of several research reports. UBS Group set a $79.00 price target on shares of Centene in a research note on Tuesday, August 18th. JPMorgan Chase & Co. increased their price objective on Centene from $60.00 to $67.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Sanford C. Bernstein reissued an “outperform” rating and set a $79.00 target price (up from $68.00) on shares of Centene in a research note on Monday, August 3rd. Barclays restated an “overweight” rating and set a $80.00 price target (up from $75.00) on shares of Centene in a report on Wednesday, July 29th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $70.05.

Check Out Our Latest Analysis on Centene

Centene Stock Performance

NYSE:CNC opened at $66.92 on Friday. The business’s fifty day moving average price is $65.56 and its 200 day moving average price is $54.18. The firm has a market capitalization of $33.06 billion, a PE ratio of -6.41, a price-to-earnings-growth ratio of 0.43 and a beta of 1.10. Centene Corporation has a 12 month low of $28.24 and a 12 month high of $69.36. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings data on Monday, July 27th. The company reported $2.51 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $1.42. The business had revenue of $53.58 billion for the quarter, compared to the consensus estimate of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The business’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.16) EPS. On average, sell-side analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.

About Centene

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Stories

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.